It has been indicated that the mammalian target of rapamycin (mTOR), an inhibitory-like pathway in autophagy, is activated in IBD animals and inhibits autophagy in intestinal epithelial cells through the NF-κB pathway to regulate intestinal inflammation (48). The gene discussed is NFKB1; the disease is inflammatory bowel disease.